STR Webinar: Understanding Section 232 Trade Actions in the Pharmaceutical Sector
About The Webinar
The new Section 232 tariffs on pharmaceuticals raise broader legal, compliance, and supply chain considerations for companies operating in this sector. This webinar will examine what these measures may mean for manufacturers, importers, and downstream market participants. Our speaker will discuss the practical challenges companies may face in assessing exposure, managing compliance risk, and planning for operational disruption, as well as what steps companies can take to respond.
Key Topics
Explanation of the new Section 232 tariffs on pharmaceuticals
Key compliance and reporting considerations triggered by Section 232 trade actions
